Versus its own history, the P/B of 1.17 suggests the market values the equity near book, which may reflect the sharp decline in shareholder equity from $7.3 billion to $4.2 billion over recent quarters. The growth implied by the forward P/E is not clearly supported by the reported revenue decline of roughly 7.2% year over year, so the multiple warrants further investigation before it is treated as a value signal. The 0.55 price-to-sales and 6.53 price-to-free-cash-flow multiples look undemanding, but they rely on volatile quarterly cash flow that may not repeat.

Analysts should treat the large negative net margins in 2024Q4 and 2025Q3 as distorted by discrete charges rather than run-rate earnings, and the 2.9% net margin in the latest period is the more representative signal. The gap between operating and net margin in clean quarters suggests interest expense and tax are absorbing a substantial share of operating profit. A continued gross margin slide would compress operating margin further given SG&A has held near $230 to $260 million per quarter.

The rise in leverage reflects both debt funding and a shrinking equity base after large charges, so the deterioration is partly accounting-driven and partly economic. Interest coverage near 1.5x in the latest quarter leaves little room for further margin compression, which may pressure refinancing flexibility. Covenant and refinancing terms are not included in the supplied data, so the severity of this risk cannot be confirmed from the figures alone.

Days inventory outstanding above 100 in most quarters may reflect slow-moving stock or a deliberate buffer against feedstock volatility, and the supplied data cannot distinguish between the two. DPO near 60 to 68 days indicates meaningful reliance on supplier financing, which may be sensitive to supplier credit conditions. The improvement in CCC from its 2024Q4 peak is directionally positive but does not yet confirm a sustained efficiency gain.